Clinical Trial Update: Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiation with concomitant and sequential temozolomide for newly diagnosed supratentorial malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Kentuckiana Cancer Institute | Conditions: Newly Diagnosed Supratentorial Malignant Glioma | Phase 2 | Status: UNKNOWN